joint with DNA Methylation
Organizer(s): Bing Ren and Daniel ZilbermanDate: March 29 - April 03, 2015
Location: Keystone Resort, Keystone, CO, USA
Heritable, covalent modifications to DNA and histone proteins play an important role in an organism’s development and survival. Such epigenetic mechanisms have been increasingly linked to risks to a broad spectrum of human diseases. However, the exact function of epigenetic marks in development and disease pathogenesis remains to be better understood. With the help of recent technological advances in DNA sequencing technologies, epigenetic regulatory mechanisms have been investigated in a growing number of organisms at increasingly high resolution and scope. The results are an explosion in new genomic technologies, large-scale datasets and computational resources. The growing research field is now referred to as “epigenomics.” Epigenomics is still a young and growing field, and there are many challenges to investigators working on specific model organisms or disease who want to adopt this approach. This meeting is designed to capture the recent progress in the field in the same time bridge the technological gaps in the field, such as dataset availability, method adoption, data interpretation.
Scholarship Deadline: December 3 2014
Discounted Abstract Deadline: December 3 2014
Abstract Deadline: January 8 2015
Discounted Registration Deadline: January 29 2015
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Human Genome Research Institute (NHGRI)
Grant No. 1R13HG008333-01
Funding for this conference was made possible (in part) by 1 R13 HG 008333 - 01 from National Human Genome Research Institute (NHGRI) and the Office of the Director, National Institutes of Health (OD/NIH). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.